Avanos Medical (AVNS) Interest Coverage Ratio Growth (3y) (2016 - 2026)
Avanos Medical (AVNS) Interest Coverage Ratio Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -20.77% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.34% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 18.67% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 15.93% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -50.44% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 43.57% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 75.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.81% |
| Dec 31, 2025 | -59.09% |
| Sep 30, 2025 | -77.17% |
| Jun 30, 2025 | -162.56% |
| Mar 31, 2025 | 38.20% |
| Dec 31, 2024 | -67.16% |
| Sep 30, 2024 | 31.62% |
| Jun 30, 2024 | 36.75% |
| Mar 31, 2024 | 30.22% |
| Dec 31, 2023 | 29.94% |
| Sep 30, 2023 | 116.86% |
| Jun 30, 2023 | 7.14% |
| Mar 31, 2023 | -256.32% |
| Dec 31, 2022 | 111.31% |
| Sep 30, 2022 | 78.19% |
| Jun 30, 2022 | 84.20% |
| Mar 31, 2022 | 40.88% |
| Dec 31, 2021 | -293.62% |
| Sep 30, 2021 | 50.71% |
| Jun 30, 2021 | -84.48% |